| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Institut National de la Recherche Agronomique, Physiologie de la Reproduction des Mammiferes Domestiques (D.C.S., B.M.), Nouzilly 37380, France; and The Babraham Institute (D.C.S.), Babraham, Cambridge, United Kingdom CB2 4AT
Address all correspondence and requests for reprints to: Dr. Donal C. Skinner, Department of Clinical Veterinary Science, University of Bristol, Langford, United Kingdom BS40 5DU.
Melatonin has been implicated in several neurotropic effects, but few studies have investigated the bioavailability of melatonin in the brain. The discovery of periventricular sites of action adjacent to the third ventricle forced us to investigate the dynamics of cerebrospinal fluid (CSF) melatonin release and the source of this melatonin. Our first study demonstrated unequivocally that third ventricle CSF melatonin, like jugular plasma melatonin, accurately reflects the duration of the night and is rapidly suppressed by light. However, third ventricle CSF melatonin levels are 20-fold higher than nocturnal plasma concentrations. A further study showed that melatonin increased in plasma before third ventricle CSF, raising the possibility that melatonin is taken up from the blood after recirculation through the Galen vein. However, a final experiment suggested strongly that CSF melatonin is released directly into the third ventricle, as melatonin levels in the lateral ventricle were 7-fold lower than those in the third ventricle. Our study raises the possibility that there may be two compartments of melatonin affecting physiological functioning: the first in plasma acting on peripheral organs, and the second in the CSF affecting neurally mediated functions at a much higher concentration of this pineal indoleamine.
This article has been cited by other articles:
![]() |
T. Lialiaris, E. Lyratzopoulos, F. Papachristou, M. Simopoulou, C. Mourelatos, and N. Nikolettos Supplementation of melatonin protects human lymphocytes in vitro from the genotoxic activity of melphalan Mutagenesis, May 22, 2008; (2008) gen020v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bechtold and A. S. I. Loudon Hypothalamic Thyroid Hormones: Mediators of Seasonal Physiology Endocrinology, August 1, 2007; 148(8): 3605 - 3607. [Full Text] [PDF] |
||||
![]() |
T. W. Fischer, T. W. Sweatman, I. Semak, R. M. Sayre, J. Wortsman, and A. Slominski Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems FASEB J, July 1, 2006; 20(9): 1564 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ma, J. R. Idle, K. W. Krausz, and F. J. Gonzalez METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450 Drug Metab. Dispos., April 1, 2005; 33(4): 489 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Reiter, D.-x. Tan, J. Leon, U. Kilic, and E. Kilic When Melatonin Gets on Your Nerves: Its Beneficial Actions in Experimental Models of Stroke Experimental Biology and Medicine, February 1, 2005; 230(2): 104 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. W Rajaratnam, B. Middleton, B. M Stone, J. Arendt, and D.-J. Dijk Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans J. Physiol., November 15, 2004; 561(1): 339 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. W. Rajaratnam, D.-J. Dijk, B. Middleton, B. M. Stone, and J. Arendt Melatonin Phase-Shifts Human Circadian Rhythms with No Evidence of Changes in the Duration of Endogenous Melatonin Secretion or the 24-Hour Production of Reproductive Hormones J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4303 - 4309. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nakahara, M. Nakamura, M. Iigo, and H. Okamura Bimodal circadian secretion of melatonin from the pineal gland in a living CBA mouse PNAS, August 5, 2003; 100(16): 9584 - 9589. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wolfler, P. M. Abuja, W. Linkesch, K. Schauenstein, P. M. Liebmann, Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Questionable Benefit of Melatonin for Antioxidant Pharmacologic Therapy J. Clin. Oncol., October 1, 2002; 20(19): 4127 - 4129. [Full Text] [PDF] |
||||
![]() |
Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tricoire, A. Locatelli, P. Chemineau, and B. Malpaux Melatonin Enters the Cerebrospinal Fluid through the Pineal Recess Endocrinology, January 1, 2002; 143(1): 84 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. MacGibbon, R. S. Walls, and A. V. Everitt An Age-Related Decline in Melatonin Secretion Is Not Altered by Food Restriction J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 21B - 26. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |